Grants and Awards

We highly value creativity, initiative and innovation. So, it’s very important to us that we recognize scientists, students and entrepreneurs who exhibit these qualities in outstanding work.


Biopharma Innovation Cup

Join the brightest students from all over the world for a week at the company headquarters. Learn from professionals, network, develop a business plan, and win a team prize! Learn more

Displaying Futures Award

With this award we recognize breakthrough ideas and entrepreneurial spirit in the field of Performance Materials. The winning teams receive extensive funding and mentorship from our experts to further explore and develop their idea. Learn more

Emanuel M. Lectureship

The Emanuel M. Lectureship was established in 1992 and is given in partnership with Technical University, Darmstadt, Germany. It recognizes globally renowned scientists for outstanding contributions to chemical and pharmaceutical research. Learn more

Emerging Biotech Grant Program

We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why we have developed our EB Grant programs that we run on a regular basis in different regions of the world. These programs allow grant recipients to receive free products and services. Learn more

Future Insight Prize

Stimulating scientific and technological progress in the areas of health, nutrition, and energy. Learn more

2020 Research Grants

We are offering a series of research grants to stimulate innovative research in challenging areas of future importance. In 2020, grants of 100,000 EUR - 500,000 EUR per year for up to 3 years are availabe in the areas of:  Drug discovery, Bioreactor design for cultured meat, Next generation machine learning, Pandemic preparedness / fighting new emerging viral infectious disease. Learn more

Global Grants for Medical Education

In order to promote advances in the field of medicine, we offer grants to independent medical education providers to design and deliver advanced medical training across the world enhancing medical practice for the ultimate benefit of patients. Learn more

Latest News on Grants and Awards

View All News
  1. Press Releases

    BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New ...

    Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono, Inc. in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the..

    2020/09/18

  2. Press Releases

    FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment ...

    Merck KGaA, Darmstadt, Germany, today announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review to the new drug application (NDA) for once-daily, orally-dosed tepotinib*

    2020/08/25

  3. Press Releases

    NICE Recommends BAVENCIO® (Avelumab) in Combination with Axitinib ...

    This is the first combination of an immunotherapy with a targeted antiangiogenic therapy to be recommended by NICE as a first-line treatment option for aRCC for use within the Cancer Drugs Fund.

    2020/07/31

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement